The Investigation of Peginterferon Alfa-2a on Optimal in Chronic Hepatitis B Patients Who Have a High Risk of HCC
Clinical trial NCT03084250 · UNKNOWN
Trial details
- NCT number
- NCT03084250
- Sponsor
- Shanghai Nanhui Nanhua Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-10
- Primary completion
- 2023-04-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.